Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Transforming the spleen into a liver-like organ in vivo
2 Made-in-Alberta ‘robot body’ that allows lungs to stay alive between surgery helps with 12 successful transplants
3 4D physiologically adaptable cardiac patch: A 4-month in vivo study for the treatment of myocardial infarction
5 Edmonton tech company wins NASA iTech competition
6 In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
7 Tevosol Completes TMCx Accelerator Program and Opens Houston Hub for Pivotal Clinical Trial of Lung Perfusion Machine
8 Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma
9 TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells
10 Tevosol closes $1.5 million in new round of seed funding
11 Double-lung transplant on COVID-19 patient offers hope for others
12 Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
13 LiQD Cornea: Pro-regeneration collagen mimetics as patches and alternatives to corneal transplantation
14 BioMedInnovations LLC Announces US Food and Drug Administration Has Granted Emergency Use Authorization to Manufacture and Distribute SuppleVent™, a Unique and Value-Added Ventilator Technology
15 A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus
16 Tevosol Closes $2M Seed Round
17 Page 109320 – Cole Market Research
18 Portable normothermic organ care system may increase number of lungs available for transplant
19 Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling
20 Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed
21 An orthogonally regulatable DNA nanodevice for spatiotemporally controlled biorecognition and tumor treatment
22 Tau: Why Alzheimer's Worsens Fast in Some, Slowly in Others
23 miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
24 Alberta moves toward 'opt out' organ donation system
25 Edmonton hospital a world leader in transplant technology
26 Tevosol Appoints Ron Mills as CEO
27 Aiming to boost transplant availability, FDA advises on organ preservation devices
28 New transplant research aims to salvage infected donated organs
29 Tevosol Raises $2M in Seed Funding Round
30 Tevosol Announces Management and Advisory Additions and the Start of its First Investigator Lead Trial using EVOSS™
31 Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
32 Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
33 Donor lung preservation system gains expanded indication
34 FDA approves device to help increase access to more lungs for transplant
35 Noninvasive in vivo 3D bioprinting
36 Beyond cold storage: Technology designed to keep organs warm, helps liver transplant patients in key study
37 Disrupting Organ Transplants: TransMedics And In-Kind Competitors
38 Metabolic profiling during ex vivo machine perfusion of the human liver
39 ‘Parents can look at their foetus in real time’: are artificial wombs the future?
40 The breathing machine
41 Lungs in a Box
42 From rejection to renewal: the future of organ transplants
43 TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage
44 More than 200 Canadians died while waiting for organ transplants in 2018: report
45 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
46 Making more lungs available for transplant in Vancouver
47 CRISPR may help in kidney-transplants by detecting viruses
48 Little-used drug combination may extend the lives of lung transplant patients
49 Variation in transplant centers' use of less-than-ideal organs: Many organs that are discarded could benefit patients on the waitlist
50 Device Keeps Donor Kidneys Healthy Outside the Body Until Transplant
51 Non-Animal Alternatives Testing Market Outlook, 2030: Cellular Assay, Biochemical Assay, In Silico, Ex-vivo
52 Multi-organ-on-a-chip System Developed To Test Drug Toxicity
53 Theranostic OCT microneedle for fast ultrahigh-resolution deep-brain imaging and efficient laser ablation in vivo
54 Donor Kidney Transport System Preserves Organ Function
55 In vivo–mimicking microfluidic perfusion culture of pancreatic islet spheroids
56 A biomimetic peptide recognizes and traps bacteria in vivo as human defensin-6
57 Regenerative Medicine Gets Weaving
58 A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application
59 Immunology: Tonsils as a testbed
60 The Results of the OCS™ Lung INSPIRE Trial Published in The Lancet Respiratory Medicine Journal.
61 Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
62 Physicians first in Texas to transplant lungs using new technology to make more organs viable
63 Preserving donor lungs longer makes transplant more elective than emergency surgery
64 Regeneration of Severely Damaged Lungs a Transplant Game-changer
65 In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair
66 Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes Ineligible for Approved CFTR Modulators
67 CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
68 UK Transplant Researchers Seek to Fight Organ Rejection in New Trial
69 Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
70 Life After Death: Heart and lung transplant gives man second chance
71 Host nutrient milieu drives an essential role for aspartate biosynthesis during invasive Staphylococcus aureus infection
72 How Payer Value-Based Contracts Seek to Cut Gene Therapy Costs
73 CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
74 Breakthrough unlocks progress in brain-on-a-chip technology
75 Monasterium Laboratory
76 In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation
77 Where could bioengineering and technology take drug discovery?
78 Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality
79 Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
80 Bioenergetic-active materials enhance tissue regeneration by modulating cellular metabolic state
81 Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
82 TransMedics closes $51.2m round to support its Organ Care System
83 Personalized CF Medicine to be Tested for Rare Genetic Defects in Europe
84 Animal Models Evolve to Satisfy Emerging Needs
85 Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device
86 Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer
87 Kaleido Biosciences Announces Collaboration with Janssen to Explore the Potential for Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions by Promoting Healthy Function of the Gut Microbiome
88 Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers
89 Combinatorial screening approach opens path to better-quality joint cartilage
90 The Outlook for 2020 and Beyond
91 Physiology-forward identification of bile acid–sensitive vomeronasal receptors
92 Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling
93 Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles for treatment of non-Hodgkin's lymphoma
94 TransMedics Reports Second Quarter 2019 Financial Results Nasdaq:TMDX
95 University Health Network Now Largest Adult Transplant Program in North America
96 Bioluminescence-mediated longitudinal monitoring of adipose-derived stem cells in a large mammal ex vivo organ culture
97 Crohn's disease: Preserving inflammation-free phases: Early detection of Crohn's disease flare-ups leads to improved therapy options
98 Paragonix Technologies, Inc., Announces European Conformity (“CE”) for the SherpaPak™ Cardiac Transport System and SherpaPerfusion™ Cardiac Transport System
99 Global Cancer Tumor Organoids Research Insights, 2020-2025: Modeling, Technology & Personalized Cancer
100 Researchers discover new stem cells that can generate new bone